Yazar "Turgut, Burhan" için PubMed İndeksli Yayın Koleksiyonu listeleme
-
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
Başcı, Semih; Ata, Naim; Altuntaş, Fevzi; Yigenoğlu, Tuğçe Nur; Dal, Mehmet Sinan; Korkmaz, Serdal; Birinci, Şuayip; Turgut, Burhan (Springer-Verlag Italia Srl, 2022)Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance, and death during the COVID-19 course ... -
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
Akpınar, Seval; Doğu, Mehmet Hilmi; Çelik, Serhat; Ekinci, Ömer; Yönal Hindilerden, İpek; Dal, Mehmet Sinan; Altuntaş, Fevzi; Turgut, Burhan (Elsevier Inc., 2022)Introduction/Background: The emergence of novel agents targeting the B-cell receptor pathway and BCL-2 has significantly changed the therapeutic landscape of CLL. We evaluated the safety and efficacy of single-agent ibrutinib ... -
The role of oxidized phospholipids in COVID-19-associated hypercoagulopathy
Akpınar, Seval; Oran, Mustafa; Doğan, Mustafa; Çelikkol, Aliye; Erdem, İlknur; Turgut, Burhan (Verduci Editore s.r.l, 2021)OBJECTIVE: There is more pronounced hypercoagulation in COVID-19 infection than in other viral lung infections. Oxidized phospholipids (OxPLs) appear in COVID-19-infected lungs due to oxidative stress, after which they ... -
Tyrosine kinase inhibitors and COVID-19
Başçı, Semih; Yigenoğlu, Tuğçe Nur; Dal, Mehmet Sinan; Korkmaz, Serdal; Turgut, Burhan; Altuntaş, Fevzi (Sage Publications Ltd, 2020)[No Abstract Available]